Investors
Overview
Did you know that 3 out of 5 people¹ are affected by overactive inflammation? Chronic inflammation sends inflammatory signals to healthy tissue, causing cell death and tissue destruction. This can lead to a body ravaged by inflammation-based diseases. Direct Biologics aims to improve the lives of millions by investigating the use of immunity modifying extracellular vesicles to address multiple, unmet medical needs.
Company Info
Direct Biologics is a pioneering leader and cGMP manufacturer of regenerative biologic products, driven by science and innovation. Our company is dedicated to delivering cutting-edge clinical and scientific insights through research. Our science harnesses the healing properties of signaling molecules found within extracellular vesicles (EVs) to reduce overactive inflammatory responses and restore the body’s natural healing process.
News and Events
Keep up to date with Direct Biologics’ latest news and events.
Direct Biologics Announces Publication of Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Controlled Clinical Trial in the Journal CHEST
July 12, 2023
Read More →
Direct Biologics Receives FDA Clearance to Initiate Phase 1b/2a Clinical Trial of ExoFlo™ in Patients with Medically Refractory Perianal Fistulizing Crohn’s Disease
April 26, 2023
Read More →Direct Biologics Reports Compelling Data as ExoFlo™ Expanded Access Program in Hospitalized COVID-19 Patients with Moderate-to-Severe ARDS Surpasses 100 Subjects
April 26, 2023 • Read More →
Virginia mother reunited with newborn after going into COVID-induced coma
July 17, 2024 • Read More →
Investor FAQs
Why invest in Direct Biologics?
Direct Biologics is a debt free, audited company making significant progress pioneering a new class of medicine. We remain in a leadership position, investigating exciting new therapies, with potential to improve the lives of countless patients.
Who are our investors?
The Direct Biologics story resonates with people from all walks of life. Please reach out to our investor relations team to learn how you can join in our journey.
Do you qualify to invest?
Direct Biologics offers investment opportunities to all accredited investors. We enjoy giving this opportunity to small and large investors who see the vision of creating a new way to treat diseases. If you want to make a difference in the lives of patients, this is an investment you may want to consider.
How do I get involved?
To learn more about investing in Direct Biologics, please contact our investment team.
Pipeline
To learn more about Direct Biologics’ product development, visit our pipeline page here.
Contact our investment team today to learn more
Send a Message
Contact Info
Email Address
investors@directbiologics.com
Phone Number
(800) 791-1021
Mailing Address
Direct Biologics 5301 Southwest Parkway Building 1, Suite 415 Austin, Texas 78735, US
Direct Biologics
Direct Biologics is a science-based market leading innovator and certified cGMP manufacturer of regenerative biologic products.
© 2024 Direct Biologics LLC